| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |